Sympathetic Nerve Activity Is Inappropriately Increased in Chronic Renal Disease
Authors:
- Gerry LigtenbergGLGerry Ligtenberg
- Jutta NeumannJNJutta Neumann
- P. Liam OeyPOP. Liam Oey
- Hein A. KoomansHKHein A. Koomans
- Peter J. BlankestijnPBPeter J. Blankestijn
- 1 December 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (12) , 3239-3244
Abstract
The hypothesis that in hypertensive patients with renal parenchymal disease sympathetic activity is “inappropriately” elevated and that this overactivity is a feature of renal disease and not of a reduced number of nephrons per se is addressed. Fifty seven patients with renal disease (various causes, no diabetes, all on antihypertensive medication) were studied, age range 18 to 62, creatinine clearance 10 to 114 ml/min per 1.73 m2. Antihypertensives were stopped, but diuretics were allowed, to prevent overhydration. Matched control subjects were also studied. The effect of changes in fluid status was examined in seven patients while on and after stopping diuretics and in eight control subjects while on low- and high-sodium diet. Seven kidney donors were studied before and after unilateral nephrectomy. Sympathetic activity was quantified as muscle sympathetic nerve activity (MSNA) in the peroneal nerve. Mean arterial pressure, MSNA, and plasma renin activity were higher in patients than in control subjects, respectively (115 ± 12 and 88 ± 11 mmHg, 31 ± 15 and 18 ± 10 bursts/min, and 500 [20 to 6940] and 220 [40 to 980] fmol/L per s; P < 0.01 for all items). Extracellular fluid volume (bromide distribution) did not differ. Seven patients were studied again after stopping diuretics. MSNA decreased from 34 ± 18 to 19 ± 18 bursts/min (P < 0.01). Eight healthy subjects were studied during low- and high-sodium diet. MSNA was 26 ± 12 and 13 ± 7 bursts/min (P < 0.01). The curves relating extracellular fluid volume to MSNA were parallel in the two groups but shifted to a higher level of MSNA in the patients. In the kidney donors, creatinine clearance reduced by 25%, but MSNA was identical before and after donation. It is concluded that in hypertensive patients with renal parenchymal disease, sympathetic activity is inappropriately high for the volume status and that reduction of nephron number in itself does not influence sympathetic activity.Keywords
This publication has 13 references indexed in Scilit:
- Short- and Long-Term Neuroadrenergic Effects of Moderate Dietary Sodium Restriction in Essential HypertensionCirculation, 2002
- Goodpasture syndrome during the course of a Schönlein-Henoch purpuraAmerican Journal of Kidney Diseases, 2002
- Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal DiseaseCirculation, 2002
- Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal FailureNew England Journal of Medicine, 1999
- Baroreflex Impairment by Low Sodium Diet in Mild or Moderate Essential HypertensionHypertension, 1997
- Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failureKidney International, 1997
- Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart FailureCirculation, 1995
- Sympathetic Overactivity in Patients with Chronic Renal FailureNew England Journal of Medicine, 1992
- Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat.Circulation Research, 1985
- Hypertension in chronic renal failureThe American Journal of Medicine, 1973